- In 2010, generic active pharmaceutical ingredients represented the largest share of the Asia-Pacific API market,
- Influential companies profiled within the Asia-Pacific active pharmaceutical ingredients market include AstraZeneca International, GlaxoSmithKline Pharmaceuticals, Novartis, Pfizer Inc and Sanofi-Aventis.
- Indian companies exporting active pharmaceutical ingredients (APIs) to Japanese market to avoid US price erosion
LONDON--(BUSINESS WIRE)-- The market for active pharmaceutical ingredients (APIs) is highest in the US, followed by Europe and Asia Pacific – the geographic market reporting fastest growth. According to a new report on companiesandmarkets.com, revenue growth in the Asia-Pacific API market is likely to increase at a rate of 9.6% p/a between 2010-2016, following a rate of 6.7% between 2005-2010.
Active Pharmaceutical Ingredients (API) Market in Asia-Pacific to 2016 - The Merchant Market for Generics Continues to Grow as the Competition Increases
http://www.companiesandmarkets.com/Market-Report/active-pharmaceutical-ingredients-(api)-market-in-asia-pacific-to-2016-the-merchant-market-for-generics-continues-to-grow-as-the-competition-increases-624015.asp?prk=7c4ed5b510c1ffe12b50d9829eddaba2
Manufacturing of active pharmaceutical ingredients is moving from established Western markets to more emerging regions, particularly India and China. Fluctuating prices of raw materials in these countries is a cause for concern for many API production companies, as when material costs are high, profit margins are eroded – a factor which could influence growth in the Asia-Pacific API market.
In 2010, generic active pharmaceutical ingredients represented the largest share of the Asia-Pacific API market, at 71.5%, with innovator APIs accounting for the rest. The Chinese and Indian API markets have a lesser share of innovator APIs, while Japan has a much larger share. In terms of revenue, Japan and China are the highest contributors to the API market in Asia-Pacific, with 42.8% and 20.8%, respectively. India accounts for 10.3%, while South Korea holds an 8.1% share of the market.
Influential companies profiled within the Asia-Pacific active pharmaceutical ingredients market include AstraZeneca International, GlaxoSmithKline Pharmaceuticals, Novartis, Pfizer Inc and Sanofi-Aventis.
The 88 page Asia-Pacific API research report provides an in-depth explanation of the structure and dynamics of the marketplace, incorporating historic and forecast data from 2005-2016. The API markets of India, China, Japan and South Korea are also analysed individually, and include discussion of trends, growth drivers/barriers, SWOT analysis, therapeutic categories and product types, as well as other market influencing factors.
CONTACT:
Companies & Markets
Paul Chapman
Press Office
[email protected]
London (UK): +44 (0) 203 086 8600
KEYWORDS: United Kingdom Europe Asia Pacific
INDUSTRY KEYWORDS: Health Pharmaceutical
MEDIA:
| Logo |